| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |